Bletilla formosana

Bletilla formosana is a traditional herbal medicine derived from the Taiwanese ground orchid, a botanical species native to Taiwan and documented in the Taiwan Herbal Pharmacopoeia. It is currently being evaluated in clinical research for its potential therapeutic effects in metabolic disorders, specifically prediabetes. Preclinical studies suggest that Bletilla formosana possesses anti-inflammatory and antioxidant properties and may help regulate blood glucose levels. In clinical trials led by Chang Gung Memorial Hospital, it is administered as a powder to evaluate its safety, efficacy, and dose-response relationship in subjects with elevated blood sugar markers. The exact molecular mechanism is likely multi-targeted, involving the modulation of inflammatory cytokines and metabolic pathways associated with glucose homeostasis.

Other names

Taiwanese ground orchidFormosan Bletilla